Common Contracts
1000 similar Registration Rights Agreement contracts by Duos Technologies Group, Inc., Mangoceuticals, Inc., Optimus Healthcare Services, Inc., others
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • April 19th, 2024 • SuperCom LTD • Semiconductors & related devices
This Registration Rights Agreement (this “Agreement”) is made and entered into as of April 18, 2024, between SuperCom Ltd., an Israel corporation (the “Company”), and each of the several purchasers signatory hereto (each such purchaser, a “Purchaser” and, collectively, the “Purchasers”).
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • April 18th, 2024 • Korro Bio, Inc. • Pharmaceutical preparations
This Registration Rights Agreement (this “Agreement”) is made and entered into as of April 17, 2024, among Korro Bio, Inc., (the “Company”), a Delaware corporation, and each of the several purchasers signatory hereto (each such purchaser, a “Purchaser” and. collectively, the “Purchasers”).
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • April 17th, 2024 • Marpai, Inc. • Services-misc health & allied services, nec
This Registration Rights Agreement (this “Agreement”) is made and entered into as of April 15, 2024, between Marpai Inc., a Delaware corporation (the “Company”), and each of the several purchasers signatory hereto (each such purchaser, a “Purchaser” and, collectively, the “Purchasers”).
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • April 15th, 2024 • Titan Environmental Solutions Inc. • Services-computer programming services
This Registration Rights Agreement (this “Agreement”) is made and entered into as of __, 2024 between Titan Environmental Solutions Inc. a Nevada corporation (the “Company”), and each of the several purchasers that is a signatory to the Purchase Agreement (each such purchaser, a “Purchaser” and, collectively, the “Purchasers”).
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • April 12th, 2024 • Oncocyte Corp • In vitro & in vivo diagnostic substances
This Registration Rights Agreement (this “Agreement”) is made and entered into as of April 11, 2024, between Oncocyte Corporation, a California corporation (the “Company”), and each of the several purchasers signatory hereto (each such purchaser, a “Purchaser” and, collectively, the “Purchasers”).
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • April 11th, 2024 • Mangoceuticals, Inc. • Services-misc health & allied services, nec
This Registration Rights Agreement (this “Agreement”) is made and entered into as of April 4, 2024, between Mangoceuticals, Inc. (the “Company”), a corporation organized under the laws of the State of Texas, and each of the several purchasers signatory hereto (each such purchaser, a “Purchaser” and, collectively, the “Purchasers”).
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • April 11th, 2024 • Mangoceuticals, Inc. • Services-misc health & allied services, nec
This Agreement is made pursuant to the Equity Purchase Agreement, dated as of the date hereof, between the Company and Platinum Point Capital LLC (the “ELOC”).
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • April 5th, 2024 • Safety Shot, Inc. • Perfumes, cosmetics & other toilet preparations
This Agreement is made pursuant to the Securities Purchase Agreement, dated as of the date hereof, between the Company and the Purchaser (the “Purchase Agreement”).
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • April 4th, 2024 • Carmell Corp • Surgical & medical instruments & apparatus
This Registration Rights Agreement (this “Agreement”) is made and entered into as of April [__], 2024, between Carmell Corporation, a Delaware corporation (the “Company”), and each of the purchasers identified on the signature page hereto (including its successors and assigns, a “Purchaser” and, collectively, the “Purchasers”).
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • April 3rd, 2024 • Movano Inc. • Electromedical & electrotherapeutic apparatus
This Registration Rights Agreement (this “Agreement”) is made and entered into as of , 2024, between Movano, Inc., a Delaware corporation (the “Company”), and the persons listed on the Schedule of Buyers attached to the Purchase Agreement (as defined below) (each such purchaser, a “Purchaser” and, collectively, the “Purchasers”).
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • April 2nd, 2024 • Applied UV, Inc. • Electric lighting & wiring equipment
This Agreement is made pursuant to the Securities Purchase Agreement, dated as of the date hereof, between the Company and each Purchaser (the “Purchase Agreement”).
form of series e REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • March 25th, 2024 • Duos Technologies Group, Inc. • Services-prepackaged software
form of series d REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • March 25th, 2024 • Duos Technologies Group, Inc. • Services-prepackaged software
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • March 19th, 2024 • Delcath Systems, Inc. • Surgical & medical instruments & apparatus
This Agreement is made pursuant to the Securities Purchase Agreement, dated as of the date hereof, between the Company and each Purchaser (the “Purchase Agreement”).
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • March 15th, 2024 • GAXOS.AI Inc. • Services-prepackaged software
This Registration Rights Agreement (this “Agreement”) is made and entered into as of March 13, 2024, by and between Gaxos.ai Inc., a Delaware corporation (the “Company”), and each of the several purchasers signatory hereto (each such purchaser, a “Purchaser” and, collectively, the “Purchasers”).
AMENDED AND RESTATED REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • March 14th, 2024 • Optimus Healthcare Services, Inc. • Services-commercial physical & biological research
The undersigned hereby provides the following information to the Company and represents and warrants that such information is accurate:
AMENDED AND RESTATED REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • March 14th, 2024 • Optimus Healthcare Services, Inc. • Services-commercial physical & biological research
The undersigned hereby provides the following information to the Company and represents and warrants that such information is accurate:
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • March 13th, 2024 • Intelligent Bio Solutions Inc. • Surgical & medical instruments & apparatus
This Registration Rights Agreement (this “Agreement”) is made and entered into as of March 8, 2024, between Intelligent Bio Solutions Inc., a Delaware corporation (the “Company”), and each of the several purchasers signatory hereto (each such purchaser, a “Purchaser” and, collectively, the “Purchasers”).
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • February 5th, 2024 • Adverum Biotechnologies, Inc. • Biological products, (no disgnostic substances)
This Registration Rights Agreement (this “Agreement”) is made and entered into as of February 5, 2024, between Adverum Biotechnologies, Inc., a Delaware corporation (the “Company”), and each of the several investors signatory hereto (each, an “Investor” and, collectively, the “Investors”).
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • February 2nd, 2024 • cbdMD, Inc. • Perfumes, cosmetics & other toilet preparations
This Registration Rights Agreement (this “Agreement”) is made and entered into as of January 30, 2024 between cbdMD, Inc. a North Carolina corporation (the “Company”), and each of the several purchasers that is a signatory to the Purchase Agreement (each such purchaser, a “Purchaser” or “Holder” and, collectively, the “Purchasers” or “Holders”).
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • February 1st, 2024 • Lantheus Holdings, Inc. • In vitro & in vivo diagnostic substances
This Agreement is made pursuant to the Investment Agreement, dated as of January 8, 2024, between the Company and the Investor (as amended, amended and restated or otherwise modified from time to time, the “Investment Agreement”), pursuant to which the Company is selling to the Investor, and the Investor is purchasing from the Company, in each case on the Closing Date (as defined in the Investment Agreement), an aggregate of 56,342,355 shares (the “Shares”) of common stock, $0.001 par value of the Company (the “Common Stock”).
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • January 31st, 2024 • Rail Vision Ltd. • Railroad equipment
This Registration Rights Agreement (this “Agreement”) is made and entered into as of January [___], 2024, between Rail Vision Ltd., an Israeli company (the “Company”), and each of the several purchasers signatory hereto (each such purchaser, a “Purchaser” and, collectively, the “Purchasers”).
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • January 30th, 2024 • Microbot Medical Inc. • Surgical & medical instruments & apparatus
This Registration Rights Agreement (this “Agreement”) is made and entered into as of January 26, 2024, between Microbot Medical Inc., a Delaware corporation (the “Company”), and each of the several entities signatory hereto (each such entity, a “Plaintiff” and, collectively, the “Plaintiffs”).
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • January 24th, 2024 • Outlook Therapeutics, Inc. • Biological products, (no disgnostic substances)
This Registration Rights Agreement (this “Agreement”) is made and entered into as of January 22, 2024, between Outlook Therapeutics, Inc., a Delaware corporation (the “Company”), and each of the several investors signatory hereto (each, an “Investor” and, collectively, the “Investors”).
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • January 24th, 2024 • Outlook Therapeutics, Inc. • Biological products, (no disgnostic substances)
This Registration Rights Agreement (this “Agreement”) is made and entered into as of January 22, 2024, between Outlook Therapeutics, Inc., a Delaware corporation (the “Company”), and Syntone Ventures, LLC (the “Investor”).
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • January 16th, 2024 • Clearmind Medicine Inc. • Pharmaceutical preparations
This Registration Rights Agreement (this “Agreement”) is made and entered into as of January 11, 2024, between Clearmind Medicine Inc., a British Columbia corporation (the “Company”), and each of the several purchasers signatory hereto (each such purchaser, a “Purchaser” and, collectively, the “Purchasers”).
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • January 5th, 2024 • Aditxt, Inc. • Pharmaceutical preparations
The undersigned hereby provides the following information to the Company and represents and warrants that such information is accurate:
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • January 5th, 2024 • PolyPid Ltd. • Surgical & medical instruments & apparatus
The undersigned hereby provides the following information to the Company and represents and warrants that such information is accurate:
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • December 28th, 2023 • Meihua International Medical Technologies Co., Ltd. • Surgical & medical instruments & apparatus
This Registration Rights Agreement (this “Agreement”) is made and entered into as of December 27, 2023 between Meihua International Medical Technologies Co., Ltd., an exempted company incorporated under the laws of the Cayman Islands (the “Company”), and each of the several purchasers signatory hereto (each such purchaser, a “Purchaser” and, collectively, the “Purchasers”).
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • December 28th, 2023 • Trevena Inc • Pharmaceutical preparations
This Registration Rights Agreement (this “Agreement”) is made and entered into as of December 27, 2023, by and between Trevena, Inc., a Delaware corporation (the “Company”), and each of the several purchasers signatory hereto (each such purchaser, a “Purchaser” and, collectively, the “Purchasers”).
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • December 26th, 2023 • Entera Bio Ltd. • Biological products, (no disgnostic substances)
This Registration Rights Agreement (this “Agreement”) is made and entered into as of December [ ], 2023, between Entera Bio Ltd., a company organized under the laws of the State of Israel (the “Company”), and each of the purchasers signatory hereto (each such purchaser, a “Purchaser” and, collectively, the “Purchasers”).
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • December 22nd, 2023 • Vision Marine Technologies Inc. • Ship & boat building & repairing
This Registration Rights Agreement (this “Agreement”) is made and entered into as of December 13, 2023, between Vision Marine Technologies Inc. (the “Company”), a corporation organized under the laws of Quebec, Canada, and each of the several purchasers signatory hereto (each such purchaser, a “Purchaser” and, collectively, the “Purchasers”).
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • December 21st, 2023 • Evaxion Biotech a/S • Biological products, (no disgnostic substances) • New York
This Registration Rights Agreement (this “Agreement”) is made and entered into as of December 18, 2023, between Evaxion Biotech A/S, a public limited liability company incorporated under the laws of the Kingdom of Denmark (the “Company”), and each of the several purchasers signatory hereto (each such purchaser, a “Purchaser” and, collectively, the “Purchasers”).
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • December 20th, 2023 • Actelis Networks Inc • Communications equipment, nec
This Registration Rights Agreement (this “Agreement”) is made and entered into as of December 17, 2023, between Actelis Networks, Inc., a Delaware corporation (the “Company”), and each of the several purchasers signatory hereto (each such purchaser, a “Purchaser” and, collectively, the “Purchasers”).
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • December 13th, 2023 • Isun, Inc. • Semiconductors & related devices
This Registration Rights Agreement (this “Agreement”) is made and entered into as of December 12, 2023 between iSun, Inc., a Delaware corporation (the “Company”), and each of the several purchasers signatory hereto (each such purchaser, a “Holder” and, collectively, the “Holders”).
